Profil
Henry M.
Dachowitz has been a Director of Lev Pharmaceuticals, Inc. since November 28, 2007 and an Independent Financial and Business Management Consultant since 2006.
He was Treasurer of Nassau County New York.
Mr. Dachowitz was an Auditor of Coopers & Lybrand, a Research Analyst with Sanford C.
Bernstein & Company and Chief Financial Officer of Pharmos Corporation.
He was a Member of the Student Advisory Committee of the Institute of Politics at the Kennedy School of Government at Harvard University and an Editorial Advisor of the Journal of Accountancy from 1989 to 1999.
Mr. Dachowitz is a Certified Public Accountant and received a Bachelor of Science degree from Brooklyn College and a Masters in Business Administration from Harvard Business School.
Anciens postes connus de Henry M. Dachowitz
| Sociétés | Poste | Fin |
|---|---|---|
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Directeur/Membre du Conseil | 22/10/2008 |
Formation de Henry M. Dachowitz
| Brooklyn College | Undergraduate Degree |
| Harvard University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Health Technology |
